These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15980862)

  • 1. Dynein mutations impair autophagic clearance of aggregate-prone proteins.
    Ravikumar B; Acevedo-Arozena A; Imarisio S; Berger Z; Vacher C; O'Kane CJ; Brown SD; Rubinsztein DC
    Nat Genet; 2005 Jul; 37(7):771-6. PubMed ID: 15980862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of mutant aggregate-prone proteins by autophagy.
    Ravikumar B; Sarkar S; Rubinsztein DC
    Methods Mol Biol; 2008; 445():195-211. PubMed ID: 18425452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyneins, autophagy, aggregation and neurodegeneration.
    Rubinsztein DC; Ravikumar B; Acevedo-Arozena A; Imarisio S; O'Kane CJ; Brown SD
    Autophagy; 2005; 1(3):177-8. PubMed ID: 16874055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation.
    Wong YC; Holzbaur EL
    J Neurosci; 2014 Jan; 34(4):1293-305. PubMed ID: 24453320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.
    Waelter S; Boeddrich A; Lurz R; Scherzinger E; Lueder G; Lehrach H; Wanker EE
    Mol Biol Cell; 2001 May; 12(5):1393-407. PubMed ID: 11359930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in cytoplasmic dynein lead to a Huntington's disease-like defect in energy metabolism of brown and white adipose tissues.
    Eschbach J; Fergani A; Oudart H; Robin JP; Rene F; Gonzalez de Aguilar JL; Larmet Y; Zoll J; Hafezparast M; Schwalenstocker B; Loeffler JP; Ludolph AC; Dupuis L
    Biochim Biophys Acta; 2011 Jan; 1812(1):59-69. PubMed ID: 20887786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease.
    Mitra S; Tsvetkov AS; Finkbeiner S
    J Biol Chem; 2009 Feb; 284(7):4398-403. PubMed ID: 19074152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein turnover and inclusion body formation.
    Mitra S; Tsvetkov AS; Finkbeiner S
    Autophagy; 2009 Oct; 5(7):1037-8. PubMed ID: 19838079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.
    Martín-Aparicio E; Yamamoto A; Hernández F; Hen R; Avila J; Lucas JJ
    J Neurosci; 2001 Nov; 21(22):8772-81. PubMed ID: 11698589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.
    Sarkar S; Davies JE; Huang Z; Tunnacliffe A; Rubinsztein DC
    J Biol Chem; 2007 Feb; 282(8):5641-52. PubMed ID: 17182613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
    Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC
    Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of dynein function affects α-synuclein degradation via the autophagosome-lysosome pathway.
    Li D; Shi JJ; Mao CJ; Liu S; Wang JD; Chen J; Wang F; Yang YP; Hu WD; Hu LF; Liu CF
    Int J Mol Sci; 2013 Dec; 14(12):24242-54. PubMed ID: 24351814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
    Ravikumar B; Vacher C; Berger Z; Davies JE; Luo S; Oroz LG; Scaravilli F; Easton DF; Duden R; O'Kane CJ; Rubinsztein DC
    Nat Genet; 2004 Jun; 36(6):585-95. PubMed ID: 15146184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of N-terminal Huntingtin (Htt552) accumulation by Beclin1.
    Wu JC; Qi L; Wang Y; Kegel KB; Yoder J; Difiglia M; Qin ZH; Lin F
    Acta Pharmacol Sin; 2012 Jun; 33(6):743-51. PubMed ID: 22543707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of autophagy in the clearance of mutant huntingtin: a step towards therapy?
    Ravikumar B; Rubinsztein DC
    Mol Aspects Med; 2006; 27(5-6):520-7. PubMed ID: 16973207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.
    Schipper-Krom S; Juenemann K; Jansen AH; Wiemhoefer A; van den Nieuwendijk R; Smith DL; Hink MA; Bates GP; Overkleeft H; Ovaa H; Reits E
    FEBS Lett; 2014 Jan; 588(1):151-9. PubMed ID: 24291262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.
    Wang J; Wang CE; Orr A; Tydlacka S; Li SH; Li XJ
    J Cell Biol; 2008 Mar; 180(6):1177-89. PubMed ID: 18362179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy.
    Ravikumar B; Duden R; Rubinsztein DC
    Hum Mol Genet; 2002 May; 11(9):1107-17. PubMed ID: 11978769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutation.
    Gong B; Kielar C; Morton AJ
    PLoS One; 2012; 7(7):e41450. PubMed ID: 22848498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
    Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K
    Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.